Incidence and Risk Factors of Hernia Mesh-Related Infections: A Systematic Review and Meta-Analysis

Authors

  • Qanita Izza Kemala Ananda Hospital Bekasi, Bekasi, West Java, Indonesia
  • Ghina Nabila Aisyah Surgical Oncologist, Mayapada Hospital Lebak Bulus, Jakarta, Indonesia
  • Nusaibah Hanina Najah Permata Hospital Bekasi, Bekasi, West Java, Indonesia

DOI:

https://doi.org/10.19166/med.v15i2.10977

Keywords:

incidence, risk factor, hernia, mesh

Abstract

Background: Prosthetic mesh lowers hernia‑recurrence rates but can precipitate infection; reported incidence and risk factors remain inconsistent. The objective of this systematic review and meta-analysis is to estimate the pooled incidence of hernia mesh infections and to identify the key risk factors associated with their development.
Methods: A PRISMA 2020 search of PubMed, EMBASE and Scopus identified randomised, cohort and case‑control studies that reported mesh‑related infection incidence or risk factors ≥ 3 months after adult hernia repair. Two reviewers independently screened records, appraised bias (ROBINS‑I) and graded certainty (GRADE). Random‑effects meta‑analyses generated pooled proportions and risk ratio (RR).
Result: Seven studies encompassing 57,653 repairs qualified. Infection incidence ranged 1.3 – 10.2 %; the pooled proportion was 4.9 % (95 % CI 2.6 – 7.4, I² = 87 %). Diabetes (RR 1.49, 95 % CI 1.13 – 1.97) and smoking (RR 1.43, 95 % CI 1.34 – 1.52) were consistent patient‑level risks, whereas obesity (RR 1.48, 95 % CI 0.68 – 3.22) and female sex (RR 1.08, 95 % CI 1.04 – 1.11) exerted smaller effects. Operative time > 2 h, emergency repair, large/PTFE or composite intraperitoneal meshes, and repeat surgery each roughly doubled infection odds. Certainty was low‑to‑moderate overall but high for diabetes and smoking; no publication bias was detected.
Conclusions: Roughly one in twenty mesh repairs is complicated by infection. Optimising glycaemic control, enforcing smoking cessation, shortening operations and selecting macroporous meshes may meaningfully lower risk.

References

1. Hope, W. W., & Pfeifer, C. (2025). Laparoscopic Inguinal Hernia Repair. In StatPearls. StatPearls Publishing. http://www.ncbi.nlm.nih.gov/books/NBK430826/

2. Wilson, R. B., & Farooque, Y. (2022). Risks and Prevention of Surgical Site Infection After Hernia Mesh Repair and the Predictive Utility of ACS-NSQIP. Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract, 26(4), 950–964. https://doi.org/10.1007/s11605-022-05248-6

3. He, L., Wang, X., Fan, G., & Zhao, Y. (2022). Hernia mesh infection treatment following the repair of abdominal wall hernias: A single-center experience. Frontiers in Surgery, 9, 993855. https://doi.org/10.3389/fsurg.2022.993855

4. Hall, K. K., & Lyman, J. A. (2006). Updated review of blood culture contamination. Clinical Microbiology Reviews, 19(4), 788–802. https://doi.org/10.1128/CMR.00062-05

5. Al-Hajri, A., Ghabisha, S., Ahmed, F., Al-Wageeh, S., Badheeb, M., Alyhari, Q., Altam, A., & Alsharif, A. (2023). Identification of predictive factors for surgical site infections in gastrointestinal surgeries: A retrospective cross-sectional study in a resource-limited setting. F1000Research, 12, 733. https://doi.org/10.12688/f1000research.135681.3

6. Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., … Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, n71. https://doi.org/10.1136/bmj.n71

7. Abdellah Ahmed, M. A., Hussain, Z., Rashid, N. U. A., Tanvir, S., & Khaliq, M. (2025). Evaluating the Impact of Diabetes on Hernia Management by Exploring Pathologies and Comorbidities in High-Risk Patients. Cureus. https://doi.org/10.7759/cureus.86329

8. Bueno Lledó, J., Sosa Quesada, Y., Gomez I Gavara, I., Vaqué Urbaneja, J., Carbonell Tatay, F., Bonafé Diana, S., García Pastor, P., Baquero Valdelomar, R., & Mir Pallardó, J. (2009). Infección de la prótesis en la reparación herniaria. Nuestra experiencia en 5 años. Cirugía Española, 85(3), 158–164. https://doi.org/10.1016/j.ciresp.2008.09.008

9. Cobb, W. S., Carbonell, A. M., Kalbaugh, C. L., Jones, Y., & Lokey, J. S. (2009). Infection Risk of Open Placement of Intraperitoneal Composite Mesh. The American SurgeonTM, 75(9), 762–768. https://doi.org/10.1177/000313480907500905

10. Park, H., De Virgilio, C., Kim, D. Y., Shover, A. L., & Moazzez, A. (2021). Effects of smoking and different BMI cutoff points on surgical site infection after elective open ventral hernia repair. Hernia, 25(2), 337–343. https://doi.org/10.1007/s10029-020-02190-x

11. Soare, A.-M. S., Preda, S.-D., Râmboiu, S., Cârțu, D., Pătrașcu, Ștefan, Cazacu, S., Biciușcă, V., Turcu-Știolică, A., Andronic, O., Păduraru, D. N., Daniel, I., Bințințan, V., Oprea, V., Marinescu, D., & Șurlin, V. (2023). Ventral Hernia Repair and Diabetes Mellitus—A Prospective, Observational and Comparative Study of Outcomes. Current Health Sciences Journal, 49(2), 263–272. https://doi.org/10.12865/CHSJ.49.02.263

12. Stremitzer, S., Bachleitner‐Hofmann, T., Gradl, B., Gruenbeck, M., Bachleitner‐Hofmann, B., Mittlboeck, M., & Bergmann, M. (2010). Mesh Graft Infection Following Abdominal Hernia Repair: Risk Factor Evaluation and Strategies of Mesh Graft Preservation. A Retrospective Analysis of 476 Operations. World Journal of Surgery, 34(7), 1702–1709. https://doi.org/10.1007/s00268-010-0543-z

13. Swenson, B. R., Camp, T. R., Mulloy, D. P., & Sawyer, R. G. (2008). Antimicrobial-Impregnated Surgical Incise Drapes in the Prevention of Mesh Infection after Ventral Hernia Repair. Surgical Infections, 9(1), 23–32. https://doi.org/10.1089/sur.2007.021

14. Banerjee, K., Madhyastha, R., Nakajima, Y., Maruyama, M., & Madhyastha, H. (2021). Nanoceutical Adjuvants as Wound Healing Material: Precepts and Prospects. International Journal of Molecular Sciences, 22(9), 4748. https://doi.org/10.3390/ijms22094748

15. Duarte, J., Mascarenhas-Melo, F., Pires, P. C., Veiga, F., & Paiva-Santos, A. C. (2024). Multifunctional hydrogels-based therapies for chronic diabetic wound healing. European Polymer Journal, 211, 113026. https://doi.org/10.1016/j.eurpolymj.2024.113026

16. Zabaglo, M., Leslie, S. W., & Sharman, T. (2024). Postoperative Wound Infections. In StatPearls. StatPearls Publishing. http://www.ncbi.nlm.nih.gov/books/NBK560533/

17. Whitehead, A. K., Erwin, A. P., & Yue, X. (2021). Nicotine and vascular dysfunction. Acta Physiologica (Oxford, England), 231(4), e13631. https://doi.org/10.1111/apha.13631

18. Zwicky, S. N., Gloor, S., Tschan, F., Candinas, D., Demartines, N., Weber, M., & Beldi, G. (2022). No impact of sex on surgical site infections in abdominal surgery: A multi-center study. Langenbeck’s Archives of Surgery, 407(8), 3763–3769. https://doi.org/10.1007/s00423-022-02691-6

19. Kathju, S., Nistico, L., Melton-Kreft, R., Lasko, L.-A., & Stoodley, P. (2015). Direct demonstration of bacterial biofilms on prosthetic mesh after ventral herniorrhaphy. Surgical Infections, 16(1), 45–53. https://doi.org/10.1089/sur.2014.026

20. Behbahani, S. B., Kiridena, S. D., Wijayaratna, U. N., Taylor, C., Anker, J. N., & Tzeng, T.-R. J. (2022). pH variation in medical implant biofilms: Causes, measurements, and its implications for antibiotic resistance. Frontiers in Microbiology, 13, 1028560. https://doi.org/10.3389/fmicb.2022.1028560

Downloads

Published

2026-03-10

How to Cite

Kemala, Q. I., Aisyah, G. N., & Najah, N. H. (2026). Incidence and Risk Factors of Hernia Mesh-Related Infections: A Systematic Review and Meta-Analysis. Medicinus, 15(2), 157–164. https://doi.org/10.19166/med.v15i2.10977

Issue

Section

Clinical Article